Dr. Julian Panes is senior investigator at Institut Investigacions Biomèdiques August Pi i Sunyer, and formerly the head of the IBD Unit at Hospital Clínic de Barcelona for 1996 - 2022. His research group is focused on the development of new diagnostic tools particularly imaging modalities, the identification of new molecular targets for treatment of inflammatory bowel diseases, and the development of cell therapies. He has published more than 400 manuscripts in international peer-reviewed journals, has served as a member of the Scientific Committee of the United European Gastroenterology Federation, the Scientific Committee of European Crohn’s and Colitis organization, has been member of the board of International Organization for the study of Inflammatory Bowel Disease, Associate Editor of Gut, and President of ECCO.
Selected publications from PubMed
Five-year efficacy and safety of guselkumab for moderately to severely active Crohn's disease: Results from the phase 2 GALAXI 1 trial.
Afzali A, Danese S, Panaccione R, Rubin DT, Sands BE, Reinisch W, Panés J, Van Rampelbergh R, Terry NA, Salese L, Vetter ML, Yee J, Corbett C, van Duijnhoven W, Hisamatsu T, Andrews JM, D'Haens GR, GALAXI 1 investigators
Inflamm Bowel Dis. 2026 Sep 1;32(9):1669-1682 doi: 10.1093/ibd/izag055.
Outcomes of tofacitinib dose reduction in patients with ulcerative colitis in stable remission: a long-term follow-up of the randomized RIVETING trial.
Rubin DT, Panés J, Torres J, Kobayashi T, Su C, Lawendy N, Modesto I, Segovia M, Gardiner S, Wang W, Vermeire S
Crohns Colitis 360. 2026 Jul;8(3):otag093 doi: 10.1093/crocol/otag093.
Recommendations to Standardize the Conduct of Clinical Trials Evaluating Novel Therapies for Perianal Fistulizing Crohn's Disease.
Vuyyuru SK, Hanzel J, Brar MS, Danese S, D'Haens G, Faubion WA Jr, Feagan BG, Hart A, Kotze PG, Lee MJ, Panaccione R, Panes J, Peyrin-Biroulet L, Rimola J, Sands BE, Santillan CS, Segal JP, Stoker J, Taylor SA, Archer S, Kiarasi S, Shackelton LM, Jairath V, Ma C
Clin Gastroenterol Hepatol. 2026 Jul;24(7):1928-1937 doi: 10.1016/j.cgh.2025.11.005.
Darvadstrocel in Patients With Crohn's Disease With Complex Perianal Fistulas: The ADMIRE CD II Phase 3 Randomized Trial.
Colombel JF, Garcia Olmo D, Chen ST, Serclova Z, Schwartz DA, Wexner SD, Panés J, Wu C, Zhang B, Song M, McKay C, Nazarey P, Wright E, Raffals L, Fleshner P
Gastroenterology. 2026 Jun;170(7):1562-1570 doi: 10.1053/j.gastro.2025.12.033.
Efficacy and Safety of Guselkumab for Ulcerative Colitis Through Week 92 of the QUASAR Long-Term Extension Study.
Lichtenstein GR, Allegretti JR, Rubin DT, Magro F, Bressler B, Panés J, Afif W, Samaan MA, Ye BD, Yarandi S, Germinaro M, Shipitofsky N, Miao Y, Zhang H, Dignass A, Sands BE, Hisamatsu T, Peyrin-Biroulet L
Am J Gastroenterol. 2026 May 1 doi: 10.14309/ajg.0000000000004041.
Welcome & Introduction – Dr. Steven D. Wexner (USA) Combination therapy – Treat the intestinal mucosa to treat the fistula - Dr. Sara El Ouali (UAE/USA) Who is a candidate for stem cells? - Dr. Julián Panés (Spain) Practical tips for optimizing the success of stem cell therapy - Dr. Louis J. Cohen (USA) Patient-reported outcomes in fistula surgery - Dr. Marylise Boutros (Canada) The results of stem cells for anal fistulas – Dr. Giovanna da Silva (USA) Video stem cells for anal fistulas - Dr. Phillip Fleshner (USA) Panel discussion & Closing Remarks - All faculty moderated by Dr. Steven D. Wexner (USA) *Supported by an educational grant from Takeda Pharmaceuticals U.S.A.
With Takeda
Published
Jul 2023
Welcome & Introduction - Dr. Steve Wexner (USA) Rationale and development of Stem cells - Dr. Damian Garcia Olmo, Madrid, Spain Results of stem cell treatment - Dr. Julia Panes, Hospital Clinic, Barcelona, Spain Ongoing scientific trials - Dr. David Schwartz, Vanderbilt University, Nashville, Tennessee Potential future directions and additional indications - Dr. Amy Lightner, Cleveland Clinic Foundation, Ohio Discussion and closing remarks – All faculty moderated by Dr. Steve Wexner (USA)
With Takeda
Published
Oct 2021
Help your network discover Dr. Julián Panés's clinical expertise.
